Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-'1968, a GLP-1/GIP/Glucagon Receptor Triple Agonist
PR Newswire•07/08/2026•08:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.